Conventional prognostic and predictive factors include disease stage (tumour size, nodal status and presence of distant metastases) [2], expression of oestrogen and progesterone receptors (ER and PgR, respectively) [3], immunohistochemical/molecular status of HER-2 [4], and Ki-67 expression. The gene discussed is PGR; the disease is neoplasm.